Insmed INSM Operating margin

Operating margin at other companies

Sarepta Therapeutics, Inc.SRPT

-50.8%-1.6pp

United TherapeuticsUTHR

45.3%-1.6pp

ANI PharmaceuticalsANIP

13.4%—

Regeneron PharmaceuticalsREGN

24.7%-2.3pp

Theravance BiopharmaTBPH

1.2%+0.6pp

Upstream Bio, Inc.UPB

-5,176.5%+1,764pp

FAQ

What is Insmed's operating margin?

Insmed (INSM) reported operating margin of -140.6% in Q1 2026.

How has Insmed's operating margin changed year-over-year?

Insmed's operating margin increased by 45.4% year-over-year, from -257.4% to -140.6%.

What is the long-term trend for Insmed's operating margin?

Over 5 years (2020 to 2025), Insmed's operating margin has grown at a 5.0% compound annual growth rate (CAGR), from -161.3% to -205.6%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.